What is the current prevalence and incidence rate of schizophrenia in the USA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Schizophrenia Prevalence and Incidence in the USA

The lifetime prevalence of schizophrenia in the United States is estimated to be approximately 0.7%, although findings vary depending on study methodology, demographics, and diagnostic criteria used. 1

Prevalence Data

  • The 12-month prevalence of diagnosed schizophrenia in the USA was estimated at 5.1 per 1000 lives (0.51%) based on administrative claims data analysis from 2002 2
  • Schizophrenia affects approximately 1% of the general population according to some clinical reviews 3, 4
  • The American Psychiatric Association's 2020 practice guideline cites a lifetime prevalence of approximately 0.7%, which represents the most recent authoritative estimate 1
  • Some researchers using strict research diagnostic criteria have suggested that the true prevalence may be lower than generally accepted, with hospital admission prevalence around 6% 5

Factors Affecting Prevalence Estimates

  • Prevalence estimates vary based on several methodological factors: 1
    • Study location and population demographics
    • Case-finding approaches
    • Methods used for diagnostic confirmation
    • Specific diagnostic criteria applied

Economic and Health Burden

  • The economic burden of schizophrenia in the United States was estimated at $343.2 billion in 2019, nearly doubling from $155.7 billion in 2013 6
  • This burden includes: 6
    • $251.9 billion in indirect costs (73.4%)
    • $62.3 billion in direct healthcare costs (18.2%)
    • $35.0 billion in direct non-healthcare costs (10.2%)

Mortality and Morbidity

  • Schizophrenia is associated with significantly increased mortality, with standardized mortality ratios 2-4 times higher than the general population 1
  • About 4-10% of persons with schizophrenia die by suicide, with rates highest among males early in the course of the disorder 1
  • Schizophrenia is ranked among the top 20 causes of disability worldwide 1

Risk Factors and Demographics

  • Schizophrenia affects equal numbers of men and women, though onset is often later in women 3
  • Heritability of schizophrenia is estimated to be up to 80% 4
  • If one parent has schizophrenia, the probability of offspring developing the condition is approximately 13%; if both parents have schizophrenia, the risk exceeds 20% 4
  • Environmental risk factors include birth season, place of birth, infectious diseases, pregnancy/delivery complications, substance abuse, and stress 4

Incidence Rate

  • While specific current incidence rates for the USA are not clearly stated in the provided evidence, schizophrenia incidence peaks have been observed in women aged 20-29 and 30-39 years 1

Special Populations

  • The Medicaid population has been identified with the highest prevalence rate among studied populations 2
  • Women with schizophrenia represent a particularly vulnerable population during pregnancy and childbirth, with higher risks of various complications for both mothers and infants 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Schizophrenia: a review.

American family physician, 2007

Research

Epidemiology and risk factors of schizophrenia.

Neuro endocrinology letters, 2016

Research

The Economic Burden of Schizophrenia in the United States.

The Journal of clinical psychiatry, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.